HK1207401A1 - Genetic markers for predicting responsiveness to fgf-18 compound fgf-18 - Google Patents

Genetic markers for predicting responsiveness to fgf-18 compound fgf-18

Info

Publication number
HK1207401A1
HK1207401A1 HK15107887.4A HK15107887A HK1207401A1 HK 1207401 A1 HK1207401 A1 HK 1207401A1 HK 15107887 A HK15107887 A HK 15107887A HK 1207401 A1 HK1207401 A1 HK 1207401A1
Authority
HK
Hong Kong
Prior art keywords
fgf
compound
genetic markers
predicting responsiveness
responsiveness
Prior art date
Application number
HK15107887.4A
Other languages
English (en)
Chinese (zh)
Inventor
‧雷德爾
‧貝爾通
‧瓦爾塞西亞
‧法默
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HK1207401A1 publication Critical patent/HK1207401A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15107887.4A 2012-08-06 2015-08-14 Genetic markers for predicting responsiveness to fgf-18 compound fgf-18 HK1207401A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP12179391 2012-08-06
US201261680480P 2012-08-07 2012-08-07
US201361778912P 2013-03-13 2013-03-13
PCT/EP2013/066421 WO2014023703A1 (en) 2012-08-06 2013-08-05 Genetic markers for predicting responsiveness to fgf-18 compound

Publications (1)

Publication Number Publication Date
HK1207401A1 true HK1207401A1 (en) 2016-01-29

Family

ID=50067440

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15107887.4A HK1207401A1 (en) 2012-08-06 2015-08-14 Genetic markers for predicting responsiveness to fgf-18 compound fgf-18

Country Status (10)

Country Link
US (2) US10221456B2 (xx)
EP (1) EP2880179B1 (xx)
JP (2) JP6262731B2 (xx)
CN (1) CN104736723B (xx)
AU (1) AU2013301606B2 (xx)
CA (1) CA2881024C (xx)
ES (1) ES2660818T3 (xx)
HK (1) HK1207401A1 (xx)
IL (1) IL237071B (xx)
WO (1) WO2014023703A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2881024C (en) * 2012-08-06 2021-06-15 Christoph Hubertus LADEL Genetic markers for predicting responsiveness to fgf-18 compound
CN105567847A (zh) * 2016-02-22 2016-05-11 郑州大学 一种用MspI检测人胃癌易感基因IL-1RN多态性rs9005的方法
RS63293B1 (sr) * 2017-09-29 2022-06-30 Merck Patent Gmbh Metabolički biomarkeri za predviđanje reakcije na jedinjenje fgf-18
PL3688468T3 (pl) * 2017-09-29 2022-07-18 Merck Patent Gmbh Biomarkery stanu zapalnego do przewidywania odpowiedzi na związek fgf-18
KR102463200B1 (ko) * 2017-12-08 2022-11-04 현대자동차 주식회사 차량용 도어
CN108899086A (zh) * 2018-06-11 2018-11-27 浙江大学 一种基于机器学习通过血液样本诊断骨关节炎亚型的系统
CA3111671A1 (en) * 2018-09-10 2020-03-19 Merck Patent Gmbh Markers useful in enrichment strategies for the treatment of osteoarthritis
US20220184180A1 (en) 2019-02-08 2022-06-16 Merck Patent Gmbh Treatment of patients at risk of rapid progression of osteoarthritis

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989010414A1 (en) 1988-04-28 1989-11-02 Robert Bruce Wallace AMPLIFIED SEQUENCE POLYMORPHISMS (ASPs)
DE69033179T3 (de) 1989-02-13 2005-01-27 Geneco Pty. Ltd. Nachweis einer nukleinsäuresequenz oder einer änderung darin
FR2650840B1 (fr) 1989-08-11 1991-11-29 Bertin & Cie Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications
US5302509A (en) 1989-08-14 1994-04-12 Beckman Instruments, Inc. Method for sequencing polynucleotides
US6004744A (en) 1991-03-05 1999-12-21 Molecular Tool, Inc. Method for determining nucleotide identity through extension of immobilized primer
US5605798A (en) 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
IL108159A (en) 1993-12-23 1998-02-08 Orgenics Ltd Apparatus for separation, concentration and detection of target molecules in liquid sample
DE69531542T2 (de) 1994-02-07 2004-06-24 Beckman Coulter, Inc., Fullerton Ligase/polymerase-vermittelte analyse genetischer elemente von einzelnukleotid-polymorphismen und ihre verwendung in der genetischen analyse
AU710425B2 (en) 1995-12-18 1999-09-23 Washington University Method for nucleic acid analysis using fluorescence resonance energy transfer
DK1632574T3 (da) 1996-10-16 2011-02-28 Zymogenetics Inc Fibroblast-vækstfaktor homologer
AU2003279835B2 (en) 2002-10-07 2009-09-10 Zymogenetics, Inc. Methods of administering FGF18
US7858341B2 (en) 2004-12-10 2010-12-28 Zymogenetics, Inc. FGF18 production in prokaryotic hosts
WO2008023063A2 (en) 2006-08-25 2008-02-28 Ares Trading S.A. Treatment of cartilage disorders with fgf-18
BRPI0715728A8 (pt) * 2006-08-25 2018-04-03 Ares Trading Sa tratamento de distúrbios cartilaginosos
US20100098775A1 (en) * 2008-05-02 2010-04-22 Interleukin Genetics, Inc. Detecting genetic predisposition to osteoarthritis associated conditions
US20120115137A1 (en) 2010-08-31 2012-05-10 Kornman Kenneth S Methods of Predicting Osteoarthritis
CA2881024C (en) * 2012-08-06 2021-06-15 Christoph Hubertus LADEL Genetic markers for predicting responsiveness to fgf-18 compound
RS58131B1 (sr) * 2012-08-06 2019-02-28 Merck Patent Gmbh Prognoza biomarkerima u oboljenjima hrskavice

Also Published As

Publication number Publication date
ES2660818T3 (es) 2018-03-26
CA2881024A1 (en) 2014-02-13
EP2880179B1 (en) 2017-12-13
US20190161801A1 (en) 2019-05-30
CN104736723B (zh) 2017-10-31
JP6262731B2 (ja) 2018-01-17
JP6496003B2 (ja) 2019-04-03
IL237071B (en) 2018-12-31
JP2018075019A (ja) 2018-05-17
CN104736723A (zh) 2015-06-24
WO2014023703A1 (en) 2014-02-13
EP2880179A1 (en) 2015-06-10
AU2013301606B2 (en) 2018-08-02
CA2881024C (en) 2021-06-15
US20150218637A1 (en) 2015-08-06
US10221456B2 (en) 2019-03-05
AU2013301606A1 (en) 2015-03-05
JP2015533078A (ja) 2015-11-19

Similar Documents

Publication Publication Date Title
ZA201407688B (en) Actuator predictive system
HK1207401A1 (en) Genetic markers for predicting responsiveness to fgf-18 compound fgf-18
EP2822810A4 (en) LIGHTING CONTROL SYSTEM
HRP20181358T1 (hr) Genetički markeri za predviđanje stupnja odgovora na terapiju
PT2684886E (pt) Composto de cromeno
EP2715529A4 (en) GLOBAL COMPOSITION SYSTEM
GB201107873D0 (en) Control system
EP2817630A4 (en) METHOD FOR PREDICTING THE RESPONSE TO ANTICREBREW THERAPY
EP2725017A4 (en) CHROME LINK
EP2718508A4 (en) SPEED CONTROL FOR HYDRAULIC CONTROL SYSTEM
EP2890783A4 (en) CONTROLS FOR NUCLEIC ACID TESTS
PT2669277E (pt) Composto de cromeno
EP2669278A4 (en) CHROME COMPOUND
PT2708607T (pt) Marcadores genéticos para myb28
ZA201305535B (en) Temperature control system
HK1197062A1 (en) Chromene compound
PL2557365T3 (pl) Układ kontrolny rozprowadzania płynu
EP2667284A4 (en) CONTROL SYSTEM
ZA201401203B (en) Temperature control system
EP2769507A4 (en) CANCELLATION OF CHARACTERISTICS CARRIED OUT
GB201300597D0 (en) Clearance control
EP2761853A4 (en) SOURCE-RATE CONTROL TECHNOLOGY FOR CONNECTED APPLICATION
GB201100210D0 (en) Temperature control systems
EP2798836A4 (en) CONTROL SYSTEM BASED ON CONTENT
GB201119829D0 (en) Showwer control